AVANIR Pharmaceuticals Completes Public Offering of 20M Shares

AVANIR Pharmaceuticals, Inc. AVNR today announced that it has completed the previously announced underwritten public offering of 20,000,000 shares of its common stock, offered at a price of $4.40 per share. The net proceeds to AVANIR from the sales of shares in this offering, after deducting customary underwriting discounts and commissions, were approximately $83.2 million.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsOfferingsHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!